NASDAQ$MASI
Masimo Corp. · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Masimo's financial performance declined in healthcare revenue and earnings, but gained new hospital customers and retained existing ones.
Masimo Corporation reported consolidated revenue of $455.3 million for Q2 2023, with healthcare revenue at $281.1 million and non-healthcare revenue at $174.2 million. GAAP net income was $15.7 million, or $0.29 per diluted share, while non-GAAP net income was $33.7 million, or $0.62 per diluted share. The company gained new hospital customers at a record level but is disappointed with the results due to lower inpatient volumes and delayed large orders.
- Consolidated revenue reached $455.3 million.
- Healthcare revenue amounted to $281.1 million.
- Non-healthcare revenue totaled $174.2 million.
- GAAP net income per diluted share was $0.29; Non-GAAP net income per diluted share was $0.62.
Headline financials
Revenue & EPS history
Masimo · Revenue · Quarterly
$455M
Forward guidance
The Company provided the following updated estimates for its third-quarter 2023 and full-year financial guidance: The company expects GAAP consolidated revenue of $475 to $525 million and updated full year 2023 revenue of $2,100 to $2,200 million.
Tailwinds
- Third-quarter 2023 GAAP consolidated revenue is projected between $475 million and $525 million.
- Third-quarter 2023 GAAP healthcare revenue is expected to range from $305 million to $335 million.
- Third-quarter 2023 GAAP non-healthcare revenue is forecasted between $170 million and $190 million.
- Third-quarter 2023 GAAP operating income is guided to be between $27 million and $37 million.
- Third-quarter 2023 GAAP net income per diluted share is projected between $0.19 and $0.32.
Headwinds
- Full-year 2023 healthcare revenue guidance includes year-over-year foreign currency headwinds of $1 million.
- Third-quarter 2023 revenue guidance includes year-over-year foreign currency tailwinds of $2 million.
- Guidance assumes inpatient volumes will not return to the levels we expected this year.
- The company will not receive some of the new large orders we are expecting for W1™, Rad-G™ and Rad-97™.
- The company is disappointed with its results this quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2023
-0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.6%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+17.2%
Q2 2024
Best reaction
-35.8%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.4% | |
| Q4 2025 | +0.1% | +7.4% | +0.6% | |
| Q3 2025 | -4.8% | -3.0% | -4.9% | |
| Q1 2025 | -6.5% | +1.3% | +6.5% | |
| Q4 2024 | +12.3% | +12.4% | -3.5% | |
| Q3 2024 | +13.7% | +10.2% | +14.9% | |
| Q2 2024 | +17.2% | +21.1% | +9.0% | |
| Q1 2024 | -13.0% | -11.8% | -9.6% | |
| Q4 2023 | -1.5% | -3.2% | +12.4% | |
| Q3 2023 | +2.5% | +6.6% | +30.5% | |
| Q2 2023 | -4.1% | -7.6% | -11.8% | |
| Q1 2023 | -7.0% | -8.0% | -16.1% | |
| Q4 2022 | +4.1% | +7.9% | +5.6% | |
| Q3 2022 | -12.1% | +3.1% | +10.1% | |
| Q2 2022 | +2.1% | -0.2% | -0.4% | |
| Q1 2022 | +7.5% | +8.5% | +19.8% | |
| Q4 2021 | -35.8% | -31.3% | -29.9% | |
| Q3 2021 | +1.4% | -0.7% | +0.1% | |
| Q2 2021 | -0.6% | +2.3% | +3.8% | |
| Q1 2021 | -6.9% | -5.5% | -12.4% | |
| Q4 2020 | +0.5% | +0.3% | -9.6% | |
| Q3 2020 | -5.1% | -9.0% | -0.3% | |
| Q2 2020 | -7.2% | -6.6% | -6.7% | |
| Q1 2020 | -0.6% | +1.7% | +9.3% | |
| Q4 2019 | +0.2% | -4.5% | -14.5% | |
| Q3 2019 | -1.5% | -2.2% | +4.7% | |
| Q2 2019 | -2.8% | -7.8% | -3.2% | |
| Q1 2019 | -1.5% | +1.1% | -2.9% | |
| Q4 2018 | +1.3% | +3.9% | +5.5% | |
| Q3 2018 | -2.2% | -3.3% | -4.5% | |
| Q2 2018 | +8.9% | +9.1% | +18.6% | |
| Q1 2018 | +4.3% | +7.6% | +10.2% | |
| Q4 2017 | +2.2% | -1.4% | +2.7% | |
| Q3 2017 | +1.3% | -1.0% | +2.3% | |
| Q2 2017 | -10.3% | -10.8% | -11.5% | |
| Q1 2017 | -14.2% | -17.0% | -12.5% | |
| Q4 2016 | +5.7% | +11.1% | +21.9% | |
| Q3 2016 | +5.5% | +10.7% | +12.3% | |
| Q2 2016 | +9.3% | +6.1% | +14.0% | |
| Q1 2016 | +7.7% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +4.0% | — | — | |
| Q2 2015 | +6.2% | — | — | |
| Q1 2015 | +1.0% | — | — | |
| Q4 2014 | +8.0% | — | — | |
| Q3 2014 | +7.0% | — | — | |
| Q2 2014 | -11.2% | — | — | |
| Q1 2014 | -9.1% | — | — | |
| Q4 2013 | -4.2% | — | — | |
| Q3 2013 | -9.2% | — | — | |
| Q2 2013 | +5.5% | — | — | |
| Q1 2013 | +7.5% | — | — | |
| Q4 2012 | -0.3% | — | — | |
| Q3 2012 | -1.1% | — | — | |
| Q2 2012 | -6.2% | — | — | |
| Q1 2012 | -6.6% | — | — | |
| Q4 2009 | -3.8% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | -8.4% | — | — | |
| Q1 2011 | +4.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +1.1% | — | — | |
| Q4 2010 | +1.1% | — | — | |
| Q1 2010 | +2.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro